| RS1601923388 |
RPGR
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1601923578 |
RPGR
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1601923813 |
RPGR
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1601924055 |
RPGR
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1601924111 |
RPGR
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1601924184 |
RPGR
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1601925213 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Inborn genetic diseases |
| RS1601926125 |
RPGR
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1601926772 |
RPGR
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1601927180 |
ACO2
|
Health Risk |
Pathogenic/Likely pathogenic |
Infantile cerebellar-retinal degeneration, Infantile cerebellar-retinal degeneration |
| RS1601931052 |
RPGR
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Primary ciliary dyskinesia |
| RS1601932069 |
USP27X
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS1601935630 |
DEPDC5
|
Health Risk |
Likely pathogenic |
— |
| RS1601936467 |
ACO2
|
Health Risk |
Pathogenic |
Infantile cerebellar-retinal degeneration, Infantile cerebellar-retinal degeneration |
| RS1601938489 |
CYB5R3
|
Health Risk |
Pathogenic |
Deficiency of cytochrome-b5 reductase, Deficiency of cytochrome-b5 reductase |
| RS1601938682 |
ACO2
|
Health Risk |
Likely pathogenic |
— |
| RS1601940608 |
RPGR
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1601943088 |
CYB5R3
|
Health Risk |
Pathogenic |
METHEMOGLOBINEMIA, TYPE I |
| RS1601943227 |
RPGR
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1601943268 |
RPGR
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinal dystrophy |
| RS1601943325 |
RPGR
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Primary ciliary dyskinesia |
| RS1601943462 |
RPGR
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1601945599 |
ARX
|
Health Risk |
Likely pathogenic |
Corpus callosum agenesis-abnormal genitalia syndrome, Corpus callosum agenesis-abnormal genitalia syndrome |
| RS1601945626 |
ARX
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked |
| RS1601945655 |
ARX
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked |
| RS1601946139 |
ANOS1
|
Health Risk |
Likely pathogenic |
Hypogonadotropic hypogonadism 1 with or without anosmia, Hypogonadotropic hypogonadism |
| RS1601946481 |
ARX
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS1601946492 |
ARX
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 1 |
| RS1601946502 |
ARX
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 1 |
| RS1601946658 |
ARX
|
Health Risk |
Pathogenic |
— |
| RS1601947074 |
RPGR
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1601948418 |
ARX
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 1 |
| RS1601948603 |
ARX
|
Health Risk |
Pathogenic |
X-linked lissencephaly with abnormal genitalia, X-linked lissencephaly with abnormal genitalia |
| RS1601949558 |
ARX
|
Health Risk |
Pathogenic |
Abnormal synaptic transmission, Abnormal synaptic transmission |
| RS1601950543 |
ADGRG2
|
Health Risk |
Pathogenic |
Congenital bilateral aplasia of vas deferens from CFTR mutation, Congenital bilateral aplasia of vas deferens from CFTR mutation |
| RS1601950553 |
FGD1
|
Health Risk |
Pathogenic |
Aarskog syndrome, Aarskog syndrome |
| RS1601951595 |
RPGR
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 3, Retinitis pigmentosa 3 |
| RS1601951704 |
RPGR
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1601952572 |
CNKSR2
|
Health Risk |
Likely pathogenic |
— |
| RS1601953552 |
FGD1
|
Health Risk |
Pathogenic |
Aarskog syndrome, Aarskog syndrome |
| RS1601953661 |
FGD1
|
Health Risk |
Pathogenic |
Aarskog syndrome, Aarskog syndrome |
| RS1601954686 |
FGD1
|
Health Risk |
Pathogenic |
Aarskog syndrome, Aarskog syndrome |
| RS1601957478 |
USP9X
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 99 |
| RS1601961064 |
RPGR
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Primary ciliary dyskinesia |
| RS1601961173 |
RPGR
|
Health Risk |
Pathogenic |
— |
| RS1601963938 |
AIRE
|
Health Risk |
Pathogenic/Likely pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS1601965037 |
ANOS1
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 1 with or without anosmia, Hypogonadotropic hypogonadism 1 with or without anosmia |
| RS1601968978 |
TRMU
|
Health Risk |
Pathogenic |
— |
| RS1601969230 |
AIRE
|
Health Risk |
Likely pathogenic |
— |
| RS1601969308 |
AIRE
|
Health Risk |
Pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS1601969933 |
DEPDC5
|
Health Risk |
Likely pathogenic |
— |
| RS1601970168 |
DEPDC5
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial focal epilepsy with variable foci, Epilepsy |
| RS1601970640 |
PCNT
|
Health Risk |
Pathogenic |
— |
| RS1601970824 |
DEPDC5
|
Health Risk |
Likely pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS1601972255 |
RPGR
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa 3 |
| RS1601972449 |
RPGR
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, X-linked cone-rod dystrophy 1 |
| RS1601974881 |
RPGR
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinal dystrophy |
| RS1601975780 |
TANGO2
|
Health Risk |
Pathogenic |
— |
| RS1601976527 |
FANCB
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group B, Fanconi anemia complementation group B |
| RS1601976655 |
FANCB
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group B, Fanconi anemia complementation group B |
| RS1601977105 |
TRMU
|
Health Risk |
Likely pathogenic |
Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins, Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins |
| RS1601977379 |
FANCB
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group B, Fanconi anemia complementation group B |
| RS1601977844 |
FANCB
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group B, Fanconi anemia complementation group B |
| RS1601977912 |
FANCB
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group B, Fanconi anemia complementation group B |
| RS1601978817 |
RPGR
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1601978823 |
RPGR
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1601978925 |
RPGR
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1601978991 |
RPGR
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1601982474 |
RPGR
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1601982516 |
RPGR
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1601982532 |
RPGR
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Primary ciliary dyskinesia |
| RS1601982595 |
RPGR
|
Health Risk |
Pathogenic/Likely pathogenic |
Cone-rod dystrophy, RPGR-related disorder |
| RS1601988004 |
ANOS1
|
Health Risk |
Likely pathogenic |
Hypogonadotropic hypogonadism 1 with or without anosmia, Hypogonadotropic hypogonadism 1 with or without anosmia |
| RS1602005062 |
FANCB
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group B, Fanconi anemia complementation group B |
| RS1602005335 |
FANCB
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group B, Fanconi anemia complementation group B |
| RS1602005463 |
FANCB
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group B, Fanconi anemia complementation group B |
| RS1602006627 |
FANCB
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group B, Fanconi anemia complementation group B |
| RS1602006737 |
FANCB
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group B, Fanconi anemia complementation group B |
| RS1602010382 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS1602013845 |
CNKSR2
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked |
| RS1602014500 |
OTC
|
Health Risk |
Likely pathogenic |
Ornithine carbamoyltransferase deficiency, OTC-related disorder |
| RS1602022675 |
MLC1
|
Health Risk |
Likely pathogenic |
— |
| RS1602029522 |
OTC
|
Health Risk |
Pathogenic |
Ornithine carbamoyltransferase deficiency, Ornithine carbamoyltransferase deficiency |
| RS1602029533 |
OTC
|
Health Risk |
Pathogenic |
— |
| RS1602033095 |
OTC
|
Health Risk |
Likely pathogenic |
— |
| RS1602037634 |
PCNT
|
Health Risk |
Likely pathogenic |
— |
| RS1602041478 |
EIF2S3
|
Health Risk |
Likely pathogenic |
MEHMO syndrome, MEHMO syndrome |
| RS1602043738 |
TCN2
|
Health Risk |
Pathogenic |
Transcobalamin II deficiency, Transcobalamin II deficiency |
| RS1602048728 |
FTSJ1
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 9 |
| RS1602048836 |
FTSJ1
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 9 |
| RS1602049346 |
MLC1
|
Health Risk |
Pathogenic/Likely pathogenic |
Megalencephalic leukoencephalopathy with subcortical cysts, Megalencephalic leukoencephalopathy with subcortical cysts |
| RS1602050730 |
ANOS1
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 1 with or without anosmia, Hypogonadotropic hypogonadism 1 with or without anosmia |
| RS1602051017 |
PLA2G6
|
Health Risk |
Likely pathogenic |
Infantile neuroaxonal dystrophy, Infantile neuroaxonal dystrophy |
| RS1602056443 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1602057157 |
PLA2G6
|
Health Risk |
Pathogenic/Likely pathogenic |
Infantile neuroaxonal dystrophy, Infantile neuroaxonal dystrophy |
| RS1602063709 |
MLC1
|
Health Risk |
Pathogenic |
Megalencephalic leukoencephalopathy with subcortical cysts 1, Megalencephalic leukoencephalopathy with subcortical cysts 1 |
| RS1602067592 |
AMER1
|
Health Risk |
Pathogenic/Likely pathogenic |
Cleft palate, Cleft palate |
| RS1602067633 |
AMER1
|
Health Risk |
Likely pathogenic |
Osteopathia striata with cranial sclerosis, Osteopathia striata with cranial sclerosis |
| RS1602067874 |
AMER1
|
Health Risk |
Pathogenic |
— |
| RS1602068260 |
AMER1
|
Health Risk |
Pathogenic |
Osteopathia striata with cranial sclerosis, Osteopathia striata with cranial sclerosis |